10th - 11th December 2018 Amsterdam, Netherlands
This year’s event will bring together key decision makers and innovators within this rapidly growing field. This intensive 2-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides.
Join the industry’s leading drug development executives from numerous leading organizations to discuss and hear unique take-home examples, case studies and multiple peptide drug development and delivery strategies to assist in reducing time-to-market on future drug products.
During 2018, the global Peptide Therapeutics market is expected to reach over $25 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include high-throughput approaches. Hybrid technology combining solid and liquid syntheses is also contributing to the growth of peptide therapeutics, as are novel modes of conjugation.
Connect with 200+ oligonucleotide and peptide leaders across Asia, Europe and North America during networking lunches, dinners and cocktail receptions. Join us in Amsterdam, December 2018 at the Peptides 2018
The BioTech Pharma Summit: Peptides 2018 will explore the burgeoning world of Peptide Therapeutics and how peptides are being engineered to penetrate cancer tumors and conquer unmet medical needs. Improving peptide properties, such as stability and half-life, will also be discussed, along with innovating routes of administration.
More details at: https://biotechpharmasummit.com/index.php/event/peptides-2018/